Women's Health Medicine
Volume 2, Issue 2 , Pages 22-25, March 2005

Thrombosis and pregnancy

  • Catherine Calderwood

      Affiliations

    • Catherine Calderwood is a Specialist Registrar in Obstetrics and Gynaecology at the Simpson Centre for Reproductive Health in Edinburgh, UK. She qualified from Cambridge and Glasgow universities and has recently trained in maternal medicine.
  • ,
  • Ian Greer

      Affiliations

    • Ian Greer is Consultant Obstetrician/Regius Professor and Head of Department, Department of Obstetrics and Gynaecology and Deputy Dean, Faculty of Medicine, University of Glasgow, UK. His research interests include high-risk pregnancy and medical disorders in pregnancy (particularly thrombosis and haemostasis).

Abstract 

Ten women die from thrombosis in pregnancy every year in the UK. Thromboembolism is the leading cause of maternal mortality in the UK with 25 deaths from pulmonary embolus and 5 deaths from cerebral vein thrombosis reported in the most recent Confidential Enquiry into Maternal Deaths (CEMD) 2000–2002. Substandard care was identified in over 50% of cases. Pregnancy itself is a procoagulant state, there is a 6- to 10-fold increase in the risk of venous thromboembolism compared to the non-pregnant situation. This risk is increased further in some women because of pre-existing (e.g. age >35, obesity, previous venous thromboembolism, medical conditions) or transient pregnancy-related additional risk factors (e.g. hyperemesis, pre-eclampsia, prolonged labour, excessive blood loss). Risk assessment for venous thromboembolism during the pregnancy should be undertaken, ideally prior to pregnancy or early in the first trimester and this assessment should be repeated subsequently if the woman is admitted to hospital, or develops antecedent problems. The use of appropriate thromboprophylaxis throughout the antenatal period and following delivery whether by caesarean section or vaginal delivery must be considered in the context of these risk factors. The most important aspect of substandard care in the most recent CEMD was the failure to recognise these risk factors. The diagnosis of acute venous thromboembolism using diagnostic imaging and prompt treatment with adequate dosages of anticoagulation are key issues in the subsequent prevention of maternal morbidity and mortality.

Keywords:  pregnancy , venous thromboembolism , thrombosis , maternal mortality thromboprophylaxis , antenatal , postpartum , heparin.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-1870(06)00035-7

doi:10.1383/wohm.2.2.22.63056

Women's Health Medicine
Volume 2, Issue 2 , Pages 22-25, March 2005